▶ 調査レポート

世界のアミノ酸代謝異常症薬市場規模・現状・予測（2021年-2027年）
• 英文タイトル：Global Amino Acid Metabolism Disorder Drug Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のアミノ酸代謝異常症薬市場規模・現状・予測（2021年-2027年） / Global Amino Acid Metabolism Disorder Drug Market Size, Status and Forecast 2021-2027 / QFJ1-5575資料のイメージです。• レポートコード：QFJ1-5575
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Multi User￥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
QYResearch社発行の本調査レポートでは、アミノ酸代謝異常症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルギニン、葉酸、ビタミンB6＆B12、チアミン、ビタミンD、ベタイン、カルグルミン酸、二塩酸塩サプロプテリン、その他）、用途別市場規模（フェニルケトン尿症、メープルシロップ尿症、アルギニノコハク酸血症、シトルリン血症、ホモシスチン尿症）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アミノ酸代謝異常症薬の市場動向
・企業の競争状況、市場シェア
・アミノ酸代謝異常症薬の種類別市場規模と予測2016-2027（アルギニン、葉酸、ビタミンB6＆B12、チアミン、ビタミンD、ベタイン、カルグルミン酸、二塩酸塩サプロプテリン、その他）
・アミノ酸代謝異常症薬の用途別市場規模と予測2016-2027（フェニルケトン尿症、メープルシロップ尿症、アルギニノコハク酸血症、シトルリン血症、ホモシスチン尿症）
・アミノ酸代謝異常症薬の北米市場規模2016-2027（アメリカ、カナダ）
・アミノ酸代謝異常症薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アミノ酸代謝異常症薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アミノ酸代謝異常症薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・アミノ酸代謝異常症薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、Pfizer、AMINO、Merck、Recordati、DSM、Sanofi、Kyowa Hakko Kirin、BioMarin、Swedish Orphan Biovitrum、Shine Star (Hubei) Biological Engineering）
・結論

Market Analysis and Insights: Global Amino Acid Metabolism Disorder Drug Market
The global Amino Acid Metabolism Disorder Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Amino Acid Metabolism Disorder Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Amino Acid Metabolism Disorder Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Amino Acid Metabolism Disorder Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Amino Acid Metabolism Disorder Drug market.

Global Amino Acid Metabolism Disorder Drug Scope and Market Size
Amino Acid Metabolism Disorder Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amino Acid Metabolism Disorder Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Arginine
Folic Acid
Vitamin B6 & B12
Thiamine
Vitamin D
Betaine
Carglumic Acid
Sapropterin Dihydrochloride
Others

Segment by Application
Phenylketonuria
Maple Syrup Urine Disease
Argininosuccinic Acidemia
Citrullinemia
Homocystinuria

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Pfizer
AMINO
Merck
Recordati
DSM
Sanofi
Kyowa Hakko Kirin
BioMarin
Swedish Orphan Biovitrum
Shine Star (Hubei) Biological Engineering

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Arginine
1.2.3 Folic Acid
1.2.4 Vitamin B6 & B12
1.2.5 Thiamine
1.2.6 Vitamin D
1.2.7 Betaine
1.2.8 Carglumic Acid
1.2.9 Sapropterin Dihydrochloride
1.2.10 Others
1.3 Market by Application
1.3.1 Global Amino Acid Metabolism Disorder Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Phenylketonuria
1.3.3 Maple Syrup Urine Disease
1.3.4 Argininosuccinic Acidemia
1.3.5 Citrullinemia
1.3.6 Homocystinuria
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Amino Acid Metabolism Disorder Drug Market Perspective (2016-2027)
2.2 Amino Acid Metabolism Disorder Drug Growth Trends by Regions
2.2.1 Amino Acid Metabolism Disorder Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Amino Acid Metabolism Disorder Drug Historic Market Share by Regions (2016-2021)
2.2.3 Amino Acid Metabolism Disorder Drug Forecasted Market Size by Regions (2022-2027)
2.3 Amino Acid Metabolism Disorder Drug Industry Dynamic
2.3.1 Amino Acid Metabolism Disorder Drug Market Trends
2.3.2 Amino Acid Metabolism Disorder Drug Market Drivers
2.3.3 Amino Acid Metabolism Disorder Drug Market Challenges
2.3.4 Amino Acid Metabolism Disorder Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Amino Acid Metabolism Disorder Drug Players by Revenue
3.1.1 Global Top Amino Acid Metabolism Disorder Drug Players by Revenue (2016-2021)
3.1.2 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Players (2016-2021)
3.2 Global Amino Acid Metabolism Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Amino Acid Metabolism Disorder Drug Revenue
3.4 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio
3.4.1 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amino Acid Metabolism Disorder Drug Revenue in 2020
3.5 Amino Acid Metabolism Disorder Drug Key Players Head office and Area Served
3.6 Key Players Amino Acid Metabolism Disorder Drug Product Solution and Service
3.7 Date of Enter into Amino Acid Metabolism Disorder Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Amino Acid Metabolism Disorder Drug Breakdown Data by Type
4.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Type (2016-2021)
4.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2022-2027)

5 Amino Acid Metabolism Disorder Drug Breakdown Data by Application
5.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Application (2016-2021)
5.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Amino Acid Metabolism Disorder Drug Market Size (2016-2027)
6.2 North America Amino Acid Metabolism Disorder Drug Market Size by Type
6.2.1 North America Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021)
6.2.2 North America Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027)
6.2.3 North America Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2027)
6.3 North America Amino Acid Metabolism Disorder Drug Market Size by Application
6.3.1 North America Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021)
6.3.2 North America Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027)
6.3.3 North America Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2027)
6.4 North America Amino Acid Metabolism Disorder Drug Market Size by Country
6.4.1 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2016-2021)
6.4.2 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Amino Acid Metabolism Disorder Drug Market Size (2016-2027)
7.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Type
7.2.1 Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021)
7.2.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027)
7.2.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2027)
7.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Application
7.3.1 Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021)
7.3.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027)
7.3.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2027)
7.4 Europe Amino Acid Metabolism Disorder Drug Market Size by Country
7.4.1 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2016-2021)
7.4.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size (2016-2027)
8.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Type
8.2.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Application
8.3.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region
8.4.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Amino Acid Metabolism Disorder Drug Market Size (2016-2027)
9.2 Latin America Amino Acid Metabolism Disorder Drug Market Size by Type
9.2.1 Latin America Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021)
9.2.2 Latin America Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027)
9.2.3 Latin America Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2027)
9.3 Latin America Amino Acid Metabolism Disorder Drug Market Size by Application
9.3.1 Latin America Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021)
9.3.2 Latin America Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027)
9.3.3 Latin America Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2027)
9.4 Latin America Amino Acid Metabolism Disorder Drug Market Size by Country
9.4.1 Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2016-2021)
9.4.2 Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size (2016-2027)
10.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type
10.2.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application
10.3.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country
10.4.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Amino Acid Metabolism Disorder Drug Introduction
11.2.4 Pfizer Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 AMINO
11.3.1 AMINO Company Details
11.3.2 AMINO Business Overview
11.3.3 AMINO Amino Acid Metabolism Disorder Drug Introduction
11.3.4 AMINO Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.3.5 AMINO Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Amino Acid Metabolism Disorder Drug Introduction
11.4.4 Merck Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Recordati
11.5.1 Recordati Company Details
11.5.2 Recordati Business Overview
11.5.3 Recordati Amino Acid Metabolism Disorder Drug Introduction
11.5.4 Recordati Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.5.5 Recordati Recent Development
11.6 DSM
11.6.1 DSM Company Details
11.6.2 DSM Business Overview
11.6.3 DSM Amino Acid Metabolism Disorder Drug Introduction
11.6.4 DSM Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.6.5 DSM Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Amino Acid Metabolism Disorder Drug Introduction
11.7.4 Sanofi Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Kyowa Hakko Kirin
11.8.1 Kyowa Hakko Kirin Company Details
11.8.2 Kyowa Hakko Kirin Business Overview
11.8.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Introduction
11.8.4 Kyowa Hakko Kirin Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.8.5 Kyowa Hakko Kirin Recent Development
11.9 BioMarin
11.9.1 BioMarin Company Details
11.9.2 BioMarin Business Overview
11.9.3 BioMarin Amino Acid Metabolism Disorder Drug Introduction
11.9.4 BioMarin Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.9.5 BioMarin Recent Development
11.10 Swedish Orphan Biovitrum
11.10.1 Swedish Orphan Biovitrum Company Details
11.10.2 Swedish Orphan Biovitrum Business Overview
11.10.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Introduction
11.10.4 Swedish Orphan Biovitrum Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.10.5 Swedish Orphan Biovitrum Recent Development
11.11 Shine Star (Hubei) Biological Engineering
11.11.1 Shine Star (Hubei) Biological Engineering Company Details
11.11.2 Shine Star (Hubei) Biological Engineering Business Overview
11.11.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Introduction
11.11.4 Shine Star (Hubei) Biological Engineering Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021)
11.11.5 Shine Star (Hubei) Biological Engineering Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Arginine
Table 3. Key Players of Folic Acid
Table 4. Key Players of Vitamin B6 & B12
Table 5. Key Players of Thiamine
Table 6. Key Players of Vitamin D
Table 7. Key Players of Betaine
Table 8. Key Players of Carglumic Acid
Table 9. Key Players of Sapropterin Dihydrochloride
Table 10. Key Players of Others
Table 11. Global Amino Acid Metabolism Disorder Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Amino Acid Metabolism Disorder Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Amino Acid Metabolism Disorder Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Amino Acid Metabolism Disorder Drug Market Share by Regions (2016-2021)
Table 15. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Amino Acid Metabolism Disorder Drug Market Share by Regions (2022-2027)
Table 17. Amino Acid Metabolism Disorder Drug Market Trends
Table 18. Amino Acid Metabolism Disorder Drug Market Drivers
Table 19. Amino Acid Metabolism Disorder Drug Market Challenges
Table 20. Amino Acid Metabolism Disorder Drug Market Restraints
Table 21. Global Amino Acid Metabolism Disorder Drug Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Amino Acid Metabolism Disorder Drug Market Share by Players (2016-2021)
Table 23. Global Top Amino Acid Metabolism Disorder Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2020)
Table 24. Ranking of Global Top Amino Acid Metabolism Disorder Drug Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Amino Acid Metabolism Disorder Drug Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Amino Acid Metabolism Disorder Drug Product Solution and Service
Table 28. Date of Enter into Amino Acid Metabolism Disorder Drug Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2016-2021)
Table 32. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Amino Acid Metabolism Disorder Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2016-2021)
Table 36. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2022-2027) & (US$ Million)
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product
Table 71. GlaxoSmithKline Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Amino Acid Metabolism Disorder Drug Product
Table 76. Pfizer Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. AMINO Company Details
Table 79. AMINO Business Overview
Table 80. AMINO Amino Acid Metabolism Disorder Drug Product
Table 81. AMINO Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 82. AMINO Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Amino Acid Metabolism Disorder Drug Product
Table 86. Merck Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Recordati Company Details
Table 89. Recordati Business Overview
Table 90. Recordati Amino Acid Metabolism Disorder Drug Product
Table 91. Recordati Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 92. Recordati Recent Development
Table 93. DSM Company Details
Table 94. DSM Business Overview
Table 95. DSM Amino Acid Metabolism Disorder Drug Product
Table 96. DSM Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 97. DSM Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Amino Acid Metabolism Disorder Drug Product
Table 101. Sanofi Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. Kyowa Hakko Kirin Company Details
Table 104. Kyowa Hakko Kirin Business Overview
Table 105. Kyowa Hakko Kirin Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 106. Kyowa Hakko Kirin Recent Development
Table 107. BioMarin Company Details
Table 108. BioMarin Business Overview
Table 109. BioMarin Amino Acid Metabolism Disorder Drug Product
Table 110. BioMarin Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 111. BioMarin Recent Development
Table 112. Swedish Orphan Biovitrum Company Details
Table 113. Swedish Orphan Biovitrum Business Overview
Table 114. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product
Table 115. Swedish Orphan Biovitrum Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 116. Swedish Orphan Biovitrum Recent Development
Table 117. Shine Star (Hubei) Biological Engineering Company Details
Table 118. Shine Star (Hubei) Biological Engineering Business Overview
Table 119. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product
Table 120. Shine Star (Hubei) Biological Engineering Revenue in Amino Acid Metabolism Disorder Drug Business (2016-2021) & (US$ Million)
Table 121. Shine Star (Hubei) Biological Engineering Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amino Acid Metabolism Disorder Drug Market Share by Type: 2020 VS 2027
Figure 2. Arginine Features
Figure 3. Folic Acid Features
Figure 4. Vitamin B6 & B12 Features
Figure 5. Thiamine Features
Figure 6. Vitamin D Features
Figure 7. Betaine Features
Figure 8. Carglumic Acid Features
Figure 9. Sapropterin Dihydrochloride Features
Figure 10. Others Features
Figure 11. Global Amino Acid Metabolism Disorder Drug Market Share by Application: 2020 VS 2027
Figure 12. Phenylketonuria Case Studies
Figure 13. Maple Syrup Urine Disease Case Studies
Figure 14. Argininosuccinic Acidemia Case Studies
Figure 15. Citrullinemia Case Studies
Figure 16. Homocystinuria Case Studies
Figure 17. Amino Acid Metabolism Disorder Drug Report Years Considered
Figure 18. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Amino Acid Metabolism Disorder Drug Market Share by Regions: 2020 VS 2027
Figure 21. Global Amino Acid Metabolism Disorder Drug Market Share by Regions (2022-2027)
Figure 22. Global Amino Acid Metabolism Disorder Drug Market Share by Players in 2020
Figure 23. Global Top Amino Acid Metabolism Disorder Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Amino Acid Metabolism Disorder Drug Revenue in 2020
Figure 25. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2016-2021)
Figure 26. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2022-2027)
Figure 27. North America Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Amino Acid Metabolism Disorder Drug Market Share by Type (2016-2027)
Figure 29. North America Amino Acid Metabolism Disorder Drug Market Share by Application (2016-2027)
Figure 30. North America Amino Acid Metabolism Disorder Drug Market Share by Country (2016-2027)
Figure 31. United States Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Amino Acid Metabolism Disorder Drug Market Share by Type (2016-2027)
Figure 35. Europe Amino Acid Metabolism Disorder Drug Market Share by Application (2016-2027)
Figure 36. Europe Amino Acid Metabolism Disorder Drug Market Share by Country (2016-2027)
Figure 37. Germany Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Region (2016-2027)
Figure 47. China Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Amino Acid Metabolism Disorder Drug Market Share by Type (2016-2027)
Figure 55. Latin America Amino Acid Metabolism Disorder Drug Market Share by Application (2016-2027)
Figure 56. Latin America Amino Acid Metabolism Disorder Drug Market Share by Country (2016-2027)
Figure 57. Mexico Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2016-2027)
Figure 63. Turkey Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 68. AMINO Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 70. Recordati Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 71. DSM Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 72. Sanofi Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 73. Kyowa Hakko Kirin Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 74. BioMarin Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 75. Swedish Orphan Biovitrum Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 76. Shine Star (Hubei) Biological Engineering Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

以下、関連資料のご紹介
  • 世界の糖尿病性神経障害治療薬市場規模・現状・予測（2021年-2027年）
    Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Status and Forecast 2021-2027
    QFJ1-4124 2021年6月 100Pages
    QYResearch社発行の本調査レポートでは、糖尿病性神経障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、ピル、その他）、用途別市場規模（対称性神経障害、焦点＆多巣性神経障害）、主要地域別市場規模（北米、アメリカ、欧州、アジア...
  • 世界のタバコ代謝遺伝子検査市場規模・現状・予測（2021年-2027年）
    Global Cigarette Metabolism Gene Testing Market Size, Status and Forecast 2021-2027
    QFJ1-4020 2021年6月 97Pages
    QYResearch社発行の本調査レポートでは、タバコ代謝遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝学的検査、遺伝子発現検査、診断用検査、生殖発生学的検査）、用途別市場規模（病院、診療所、診断センター）、主要地域別市場規模（北米...
  • 世界のアルコール代謝遺伝子検査市場規模・現状・予測（2021年-2027年）
    Global Alcohol Metabolism Genetic Testing Market Size, Status and Forecast 2021-2027
    QFJ1-3775 2021年6月 99Pages
    QYResearch社発行の本調査レポートでは、アルコール代謝遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査）、用途別市場規模（病院、診療所、診断センター）、主要地域別市場...
  • 世界の葉酸代謝遺伝子検査市場規模・現状・予測（2021年-2027年）
    Global Folate Metabolism Genetic Testing Market Size, Status and Forecast 2021-2027
    QFJ1-4232 2021年6月 108Pages
    QYResearch社発行の本調査レポートでは、葉酸代謝遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（第1トリメスター、第3トリメスター）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...
  • 代謝作用薬品のグローバル市場2021
    Global Metabolism Drugs Sales Market Report 2021
    QAF27783 2021年4月2日 138Pages
    本市場調査資料では、世界の代謝作用薬品市場について種類別（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）、用途別（病院、小売薬局）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販...
  • 世界のグリコーゲン代謝＆糖原病治療市場規模・現状・予測（2021年-2027年）
    Global Glycogen Metabolism and Glycogen Storage Disease Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-5757 2021年6月 109Pages
    QYResearch社発行の本調査レポートでは、グリコーゲン代謝＆糖原病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...
  • 世界の物質使用障害治療市場規模・現状・予測（2021年-2027年）
    Global Substance Use Disorder Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-4914 2021年6月 99Pages
    QYResearch社発行の本調査レポートでは、物質使用障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルコール乱用治療、ニコチン乱用治療、薬物乱用治療）、用途別市場規模（病院、クリニック、在宅医療設備）、主要地域別市場規模（北米、アメリ...
  • 世界のHPV関連疾患市場規模・現状・予測（2021年-2027年）
    Global HPV Associated Disorder Market Size, Status and Forecast 2021-2027
    QFJ1-4327 2021年6月 98Pages
    QYResearch社発行の本調査レポートでは、HPV関連疾患の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（予防、治療）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...
  • 世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）
    Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027
    QFJ1-3983 2021年6月 89Pages
    QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...
  • 世界の甲状腺障害市場規模・現状・予測（2021年-2027年）
    Global Thyroid Disorder Market Size, Status and Forecast 2021-2027
    QFJ1-6041 2021年6月 99Pages
    QYResearch社発行の本調査レポートでは、甲状腺障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（甲状腺機能低下症、甲状腺機能亢進症）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...
  • ビタミンB9(葉酸)のグローバル市場調査 2019年ビタミンB9(葉酸)のグローバル市場調査 2019年 The global Vitamin B9 (Folic Acid) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Vitamin B9 (Folic Acid) volume and value at global level, regional level and company level. From a global perspecti…
  • ビタミンB9(葉酸)のグローバル市場調査 2019年ビタミンB9(葉酸)のグローバル市場調査 2019年 The global Vitamin B9 (Folic Acid) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Vitamin B9 (Folic Acid) volume and value at global level, regional level and company level. From a global perspecti…
  • アミノ酸分析装置のグローバル市場2021アミノ酸分析装置のグローバル市場2021 Amino Acid Analyzer uses classic cation exchange chromatography and ninhydrin post-column derivatization to analyze the protein hydrolysate and the content of various free amino acids. The basic structure of the instrument is similar to ordinary HPLC, but the details are optimized for amino acid ana…
  • ビタミンC（アスコルビン酸）のグローバル市場2021ビタミンC（アスコルビン酸）のグローバル市場2021 Ascorbic acid (Vitamin C), an essential nutrient found mainly in fruits and vegetables. The body requires ascorbic acid in order to form and maintain bones, blood vessels, and skin. Ascorbic acid also promotes the healing of cuts, abrasions and wounds; helps fight infections; inhibits conversion of …
  • 代謝作用薬品のグローバル市場2021代謝作用薬品のグローバル市場2021 Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. USA is the largest supplier of Metabolism Drugs, with production revenue market share over 4…